Donor-derived cell Free DNA

DIAGNOSTIC_TEST2 trials

Sponsors

Puerta de Hierro University Hospital

Conditions

Cardiac Allograft VasculopathyHeart Transplant Rejection

Unknown Phase

Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy

CompletedNCT04791852

Puerta de Hierro University HospitalCardiac Allograft Vasculopathy

Start: 2019-01-10End: 2021-04-15Updated: 2021-09-16

Donor-derived Cell Free DNA as a New Biomarker in Cardiac Acute Rejection

Puerta de Hierro University HospitalHeart Transplant Rejection

Start: 2019-03-19End: 2022-04-30Target: 200Updated: 2021-07-22

Related Papers

Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).

2024-11-208 citations

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study.

2022-04-0611 citations